Pelareorep for treating metastatic or recurrent squamous cell carcinoma of the head and neck after platinum-based chemotherapy ID940
Discontinued
Reference number: GID-TA10397
Following on from information provided to NICE by the company in May 2020 the appraisal of Pelareorep for treating metastatic or recurrent squamous cell carcinoma of the head and neck after platinum-based chemotherapy [ID940] was suspended from NICE’s work programme. As no further information has been received from the company the topic has been discontinued.